Form Heading

Tag: Invest i

FEATURED NEWS

  • Wall Street Breakfast: Biden, Alcoa And Morgan Stanley Earnings.
    Good morning from Stockmarketrevolution.com! Markets are trading higher today, both in the United States and Europe. Traders seem to be celebrating Joe Biden’s inauguration as US President. Joseph R. …
  • VOXX International Posts Strong Sales Growth
    After delivering massive sales growth in Q3 2020, VOXX (VOXX) shareholders saw an increase of more than 57% in their share price. The company delivered quarterly net sales growth of 83% y/y along …
  • fish covered with necklace and stylish jacketHepion Pharmaceuticals Inc $HEPA: Crazy Amount Of Cash In Hand

    Balance Sheet As Of 2020-12-31

    HEPA shows $40 million in cash and cash equivalents. In my experience, the company has a good amount of cash to conduct additional R&D and increase its marketing efforts. Moreover, Hepion Pharmaceuticals Inc has positive working capital, which market participants will like. It means that HEPA can cover its short-term liabilities when they come due. HEPA's short term debt is less significant than the company's cash and cash equivalents. In my experience, Hepion Pharmaceuticals Inc may not have to worry about any liquidity risk. Moreover, the price to book value is below 1. 5x, which means that HEPA is undervalued. Hepion Pharmaceuticals Inc has $48 million in total assets, and $8 million in total liabilities. In my experience, HEPA is cheap. Additionally, notice that the cash per share is equal to $4, and the stock price is $1. 91. HEPA's debt to equity ratio is below 2x. In short, the debt level appears to be under control. Note that Hepion Pharmaceuticals Inc reports cash and cash equivalents of $40 million, and net debt of $-40 million. With regards to the EV/EBITDA, Hepion Pharmaceuticals Inc trades at 1. I feel that market participants will most likely appreciate this low figure. …
  • Kandi Technologies: I Am A Bit Skeptical
    While KNDI (KNDI) appears quite cheap at 1.5x 2020 sales, I am quite skeptical about the company’s future. Both the Coronavirus and the decline in the oil price are not great for the stock. The …

Login to your account below

Fill the forms bellow to register

Retrieve your password

Please enter your username or email address to reset your password.